Trials & Tribulations Canine cancers as models: We have barely tapped the full potential of comparative oncology May 03, 2024Vol.50 No.18By Christina K. Lopes
FreeIn the Archives Otis Brawley discusses health disparities, UChicago pioneering oncologists on the UChicago Cancer Luminaries Podcast May 03, 2024Vol.50 No.18
Regulatory News ODAC unanimously upholds MRD as early endpoint across all settings in multiple myeloma April 26, 2024Vol.50 No.17By Jacquelyn Cobb
Conversation with The Cancer Letter Clearing the path for MRD as early endpoint in multiple myeloma April 26, 2024Vol.50 No.17By Jacquelyn Cobb
Health Equity Black patients with multiple myeloma aren’t getting autoHCT as often as others—and the disparity has widened April 26, 2024Vol.50 No.17By McKenzie Prillaman
Conversation with The Cancer Letter ARPA-H’s Andrew Carney: Join the AI Cyber Challenge to counter cyberattacks on health systems April 26, 2024Vol.50 No.17By Matthew Bin Han Ong
Conversation with The Cancer Letter “This is our time, and the time is now”—Chapman tells us about Jefferson’s final push for Comprehensive designation April 19, 2024Vol.50 No.16By Paul Goldberg
Guest Editorial Leading a Comprehensive Cancer Center—one job or two? April 19, 2024Vol.50 No.16By George J. Weiner
Guest Editorial Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusionMinority Cancer Awareness Week April 19, 2024Vol.50 No.16By Kimlin Tam Ashing, Nadine J. Barrett, Kim F. Rhoads, Folakemi T. Odedina, Hayley S. Thompson and Camille C. R. Ragin
